These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 10223957

  • 1. Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.
    Wu SW, Dornbusch K, Kronvall G.
    Antimicrob Agents Chemother; 1999 May; 43(5):1294-7. PubMed ID: 10223957
    [Abstract] [Full Text] [Related]

  • 2. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.
    Fournier B, Roy PH, Lagrange PH, Philippon A.
    Antimicrob Agents Chemother; 1996 Feb; 40(2):454-9. PubMed ID: 8834897
    [Abstract] [Full Text] [Related]

  • 3. Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.
    Liu Y, Mee BJ, Mulgrave L.
    J Clin Microbiol; 1997 Sep; 35(9):2365-9. PubMed ID: 9276417
    [Abstract] [Full Text] [Related]

  • 4. Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.
    Fournier B, Lu CY, Lagrange PH, Krishnamoorthy R, Philippon A.
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1365-8. PubMed ID: 7574532
    [Abstract] [Full Text] [Related]

  • 5. beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca.
    Fournier B, Lagrange PH, Philippon A.
    Antimicrob Agents Chemother; 1996 Feb; 40(2):460-3. PubMed ID: 8834898
    [Abstract] [Full Text] [Related]

  • 6. Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins.
    Izdebski R, Fiett J, Urbanowicz P, Baraniak A, Derde LP, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Brisse S, Gniadkowski M, MOSAR WP2, WP3 and WP5 Study Groups, MOSAR WP2 WP3 and WP5 Study Groups.
    J Antimicrob Chemother; 2015 Dec; 70(12):3230-7. PubMed ID: 26318191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
    Wu SW, Dornbusch K, Göransson E, Ransjö U, Kronvall G.
    J Antimicrob Chemother; 1991 Sep; 28(3):389-97. PubMed ID: 1960120
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity.
    Nijhuis RH, Oueslati S, Zhou K, Bosboom RW, Rossen JW, Naas T.
    J Antimicrob Chemother; 2015 May; 70(5):1429-33. PubMed ID: 25630648
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular aspects of high-level resistance to sulbactam-cefoperazone in Klebsiella oxytoca clinical isolates.
    Kimura K, Arakawa Y, Ohsuka S, Ito H, Suzuki K, Kurokawa H, Kato N, Ohta M.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1988-94. PubMed ID: 8878568
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S, Dahl KH, Aasnæs B, Sundsfjord A, Naseer U.
    Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
    [Abstract] [Full Text] [Related]

  • 16. Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
    Arstila T, Auvinen H, Huovinen P.
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):468-74. PubMed ID: 7957266
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors.
    Fournier B, Lagrange PH, Philippon A.
    J Antimicrob Chemother; 1996 May; 37(5):931-42. PubMed ID: 8737143
    [Abstract] [Full Text] [Related]

  • 20. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.
    Fournier B, Gravel A, Hooper DC, Roy PH.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):850-5. PubMed ID: 10103190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.